Title of project or programme
Title of PIBasic science and preclinical development of cell transplantation for basal ganglia disorders
Principal Investigators of project/programme grant
TitleFornameSurnameInstitutionCountry
ProfessorStephenDunnettCardiff UniversityUK
Address of institution of lead PI
InstitutionCardiff University
Street AddressCardiff School of Biosciences, Life Sciences Building, Museum Avenue
CityCardiff
PostcodeCF10 3AX
Country
  • United Kingdom
Source of funding information

Medical Research Council

Total sum awarded (Euro)

1300218.87

Start date of award

01-02-2011

Total duration of award in months

36

The project/programme is most relevant to
  • Parkinson’s disease
  • Huntington’s disease
Keywords
Research abstract in English

The UK is taking an international lead in developing stem cells for cell-based therapy applicable to a broad range of diseases. The purpose of this programme application is to address the translational gap to deliver clinical-grade human neuronal cells from primary, expanded and pluripotent origins for transplantation in clinical trials of human neurodegenerative disease. We complement other stem cell programmes in establishing and maintaining the infrastructure for ethically-sourced, safe, quality-assured processing of cells of clinical grade under regulatory licence, alongside establishing relevant patient cohorts, assessment programmes and clinical trial expertise, without which advances in basic cell biology cannot progress to human use or clinical trial. A major component of this programme is to develop and refine the animal models to evaluate alternative sources of cells with predictive validity of likely functional efficacy in man. Immediate applications are set to commence using primary fetal cells in 2011-2012 in Huntingtons disease and Parkinsons disease, with subsequent applications in stoke, and using expanded fetal progenitors, pending the availability of clinical grade stem cells.

Lay summary
In which category does this research fall?
  • Basic research

    Types: Investments > €500k
    Member States: United Kingdom
    Diseases: Huntington's disease, Parkinson's disease & PD-related disorders
    Years: 2011
    Database Categories: N/A
    Database Tags: N/A

    Export as PDF